MYC and B-cell chronic lymphocytic leukemia: In addition, plasma MV upregulate the cell cycle regulator cyclin D1 and MYC protein expression in BM-MSC from CLL patients, increasing their proliferation potential and survival; however, plasma MV from CLL patients do not exert the same effect in BM-MSC from healthy donors [82].